Research graph
References from Newborn screening analytes and structural birth defects among 27,000 newborns. Local targets link to admitted publications; unresolved targets remain external evidence.
Current status of newborn screening worldwide: 2015
10.1053/j.semperi.2015.03.002 · 2015 · External reference
The Current State of Newborn Screening in the United States
10.1016/j.pcl.2018.12.007 · 2019 · External reference
Association between thyroxine levels at birth and choanal atresia or stenosis among infants in Texas, 2004–2007
10.1002/bdra.23091 · 2012 · External reference
The association between neonatal thyroxine and craniosynostosis, Texas, 2004–2007
10.1002/bdra.23077 · 2012 · External reference
The association between newborn screening analytes and childhood autism in a Texas Medicaid population, 2010–2012
10.1002/ajmg.b.32728 · 2019 · External reference
Association between Birth Defects and Cancer Risk among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births
10.1001/jamaoncol.2019.1215 · 2019 · External reference
Population study of congenital hypothyroidism and associated birth defects, Atlanta, 1979–1992
10.1002/(sici)1096-8628(19970711)71:1<29::aid-ajmg5>3.0.co;2-l · 1997 · External reference
Unresolved reference
External reference
Etiology and clinical presentation of birth defects: population based study
10.1136/bmj.j2249 · 2017 · External reference
National population-based estimates for major birth defects, 2010–2014
2019 · External reference
The influence of amino-acid supplementation, gestational age and time on thyroxine levels in premature neonates
2008 · External reference
Effects of two different doses of amino acid supplementation on growth and blood amino acid levels in premature neonates admitted to the neonatal intensive care unit: a randomized, controlled trial
10.1542/peds.2007-0545 · 2007 · External reference
Leveraging a phenome-wide approach to identify novel exposure-birth defect associations: A proof of concept using maternal smoking and a spectrum of birth defects
10.1002/bdr2.1851 · 2021 · External reference
A Comprehensive Assessment of the Associations Between Season of Conception and Birth Defects, Texas, 1999–2015
10.3390/ijerph17197120 · 2020 · External reference
Comprehensive assessment of the associations between maternal diabetes and structural birth defects in offspring: a phenome-wide association study
10.1016/j.annepidem.2020.08.006 · 2021 · External reference
NAD Deficiency, Congenital Malformations, and Niacin Supplementation
10.1056/nejmoa1616361 · 2017 · External reference
Transposition of great arteries: new insights into the pathogenesis
10.3389/fped.2013.00011 · 2013 · External reference
Congenital heart disease in maternal phenylketonuria: Report from the Maternal PKU Collaborative Study
10.1203/00006450-200105000-00005 · 2001 · External reference
Low serum fatty acid levels in pregnancies with fetal gastroschisis: A prospective study
10.1002/ajmg.a.38638 · 2018 · External reference
Metabonomic profiling of human placentas reveals different metabolic patterns among subtypes of neural tube defects
10.1021/pr4009805 · 2014 · External reference
Metabolomics of Human Amniotic Fluid and Maternal Plasma during Normal Pregnancy
10.1371/journal.pone.0152740 · 2016 · External reference
Maternal phenylketonuria: a metabolic teratogen
10.1002/(sici)1096-9926(199603)53:3<176::aid-tera5>3.0.co;2-2 · 1996 · External reference
Tyrosine supplementation in the treatment of maternal phenylketonuria
10.1093/ajcn/67.3.473 · 1998 · External reference
Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies
10.1056/nejm198011203032104 · 1980 · External reference
